Drugs / MV088
last change Oct 2021 re-read 2 minutes ago

MV088

Investigated by
Kunming Pharmaceuticals, Inc.

Trials 1 · a red edge is where a trial was stopped

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04673799 Feb → Oct 2021 Kunming Pharmaceuticals, Inc. Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MV088 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04673799
Route Subcutaneous “by subcutaneous injection” NCT04673799